Levobupivacaine
Specifications
27262-47-1CAS Number
690-076-7EC Number
(2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamideIUPAC Name
C18H28N2OChemical Formula
288.4 g/molMolecular Weight
Levobupivacaine; 27262-47-1; (S)-bupivacaine; (-)-bupivacaine; L-(-)-bupivacaine; (2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide; Levobupivacaina; Novabupi; (S)-1-Butyl-2',6'-pipecoloxylidide; L-bupivacaine; Bupivacaine, (s)-; Bupivacaine, (-)-; L-(-)-1-Butyl-2',6'-pipecoloxylidide; A5H73K9U3W; CHEBI:6149; DTXSID8048496; 2',6'-Pipecoloxylidide, 1-butyl-, L-(-)-; 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (2S)-; (s)-1-butyl-n-(2,6-dimethylphenyl)-2-piperidinecarboxamide; (2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboximidic acid; levobupivacainum; Bupivacaine (-)-; RefChem:153196; DTXCID8028470; N01BB10; 690-076-7; L(-)-Bupivacaine; (S)-(-)-Bupivacaine; (S)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide; (2S)-1-butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide; Bupivacaine (-)-form; Levobupivacaine (INN); MFCD00936851; LEVOBUPIVACAINE [INN]; Levobupivacaine [INN:BAN]; Levobupivacaine free base; Novabupi (TN); NCGC00159482-02; UNII-A5H73K9U3W; 27262-47-1 (free base); Epitope ID:1597623; SCHEMBL34537; BIDD:GT0471; LEVOBUPIVACAINE [VANDF]; GTPL7211; orb1225455; orb1307450; LEVOBUPIVACAINE [MART.]; CHEMBL1201193; LEVOBUPIVACAINE [WHO-DD]; GLXC-06557; HY-B0653; BUPIVACAINE (-)-FORM [MI]; BDBM50350791; BDBM50417951; EBC-03922; AKOS016340525; DB01002; FB19357; KS-5195; NCGC00016733-01; NCGC00159482-03; DA-54878; SY465927; CAS-18010-40-7; (S)-Bupivacaine; Ropivacaine EP Impurity A; CS-0009570; NS00077944; C07887; D08116; D87861; F600617; Q3272027; Z2242128693; (2~{S})-1-butyl-~{N}-(2,6-dimethylphenyl)piperidine-2-carboxamide; ROPIVACAINE HYDROCHLORIDE MONOHYDRATE IMPURITY A [EP IMPURITY]; 41148-30-5; OJ0Synonyms
